Company Profile
Company Core Value
Management Team
Global Markets
Home> About MicroSoy>Company Profile
大立生技總公司內景 Microbio Co. Ltd., the leading bio-technology company in Taiwan, was established in year 2000 and officially listed in the OTC market in 2006.

Being a leader in modern botanical and biotransformation drug companies, Microbio, with its platform technology is focusing on R&D and producing biomedicines which can enhance health with no side-effects, and nutritional supplements that can prevent diseases and replenish nutrients. With our breakthrough innovations in biotechnology fields, Microbio has been honored and recognized with many awards and patents.

William Lu, the chairman of Microbio Co. Ltd. believes in the spirits of righteous, perfection and service to the general public, he established MicroSoy International Inc. in beginning of 2007 with the intention to fulfill the nutrient requirements and provide tremendous business opportunity to the people. This company is a multi-level marketing direct selling company which mainly distributes and markets high quality products developed by our head company Microbio.

MicroSoy International Inc. endeavors to develop advanced botanical supplements for inner and outer nutrition. The company will start from Taiwan and expand our business scope globally, in order to deliver health and wealth to all people around the world.
  • Established Microbio Company for botanical new drug and symbiotic fermented extract development.
  • Built the first certified GMP biopharmaceutical plant at Long-Tan.
  • MS-20 was approved to enter phase III clinical trial by DOH.
  • Received the strategic industry approval from MOEA.
  • Received the National Biotechnology Development Award.
  • Evaluated demonstration of mid-/ small - scale enterprise management system by DoIT.
  • Received National Biotechnology Development award.
  • Received National Biotechnology and Medical Care Quality Award.
  • Received the first International Biotechnology & Medical Care Innovation Award for MS-20.
  • Certified by ISO 9001:2000 for design, manufacture of botanical drugs and dietary supplements.
  • Received SBIR grant from MOEA to fund botanical drug MBS-2 development on atherosclerosis.
  • Received 2003 National Biotechnology & Medical Care -Biotechnology R&D Award for MBS-2.
  • Established R&D center and obtained approval from MOEA.
  • Developed Lee Herb healthcare series products.
  • Received 2004 National Biotechnology & Medical Care -Biotechnology R&D Award for MicroSoy.
  • Exported the first container healthy drinks to Japan.
  • Built the healthy and functional foods plant at Long-Tan.
  • Microsoy received national "Health Food" certificate (No. A00062, DOH, Taiwan) with efficacy of increasing intestinal original probiotics.
  • Microsoy received national "Health Food" certificate (No. A00064, DOH, Taiwan) for modulating immunity.
  • Certified FGMP plant at Long-Tan.
  • Received 2005 National Biotechnology & Medical Care -Biotechnology R&D Award for MicroSoy & Herbiron, the first company has been granted the National Biotechnology & Medical Care - Quality Awards for continuous 4 years.
  • Stock officially listed in the OTC Exchange.
  • Microsoy received national "Health Food" certificate (No. A00082, DOH, Taiwan) for modulating blood lipids.
  • Awarded No1. in 2006 National Biotechnology & Medical Care Prize for health food products.
  • Awarded National Biotechnology & Medical Care Prize, 5 years in the row
  • Rank No.1 in National Biotechnology & Medical Care Award, 2 years in the row.
  • Instituted MicroSoy International Inc. for health food market channel and distribution.
  • "MS-20" approved for Phase II trials by FDA as oncology new drug.
  • New “Statue of the Development of Biotechnology New Drug Industry” enacted.
  • Signed exclusive licensing with DCB for diabetes and anti-arthritis new drugs.
  • Awarded 2007 National Biotechnology & Medical Care Prize for health food products, 6 years in a row.
  • US FDA granted Phase II clinical trials for MicroBio's diabetes new drug "WH-1".
  • Grand opening of MicroSoy on 26th of April at Grand Formosa Regent Taipei.
  • Granted the first biotech new drug company status by the MOEA, and is rewarded with tax deductions on investments, according to the newly enacted "Statute of the Development of Biotechnology New Drug Industry".
  • "MB-6" approved for Phase II trials by FDA as oncology new drug for colon cancer.
  • Actively participated in the 2nd Health Taiwan Expo, effectively promoted the concept of Health and LOHAS.
  • Awarded 2008 National Biotechnology & Medical Care Prize for health food products, 7 years in a row.
  • Awarded No1. in 2006 National Biotechnology & Medical Care Prize for health food products, 4 years in a row.

 
Copyright©2007 MicroSoy International Inc. All rights reserved.Designed by ERsoft.
Taipei Office Hour: Mon. ~ Fri. 09:00~18:00/ Sat. 10:00~14:00 (Closed on Sunday and Public Holidays)
3F., No.305, Sec. 3, ZhongXiao E. Rd., Taipei 106, Taiwan. TEL: +886-2-2775-4666 FAX: +886-2-2775-2493